Metabolic tumor volume and total lesion glycolysis as prognostic factors in head and neck cancer: Systematic review and meta‐analysis
- 11 September 2020
- journal article
- review article
- Published by Wiley in Head & Neck
- Vol. 42 (12) , 3744-3754
Abstract
The role of metabolic tumor volume (MTV) and total lesion glycolysis (TLG) in head and neck cancer (HNC) prognosis is not well established. We conducted a systematic review focusing on MTV and TLG measured by 18F‐FDG positron‐emission tomography in HNC. Meta‐analyses were developed, estimating hazard ratios (HRs) for overall survival (OS) and disease‐free survival (DFS). Eighteen studies were found with a total of 1512 patients. MTV‐adjusted analysis had an HR of 4.65 (95% CI = 2.04‐10.6) for DFS and 3.89 (95% CI = 1.47‐10.30) for OS. TLG‐unadjusted analysis had an HR of 3.19 (95% CI = 2.33‐4.37) for DFS and 2.48 (95% CI = 1.82‐3.39) for OS. TLG‐adjusted analysis for DFS obtained an HR of 2.05 (95% CI = 0.96‐4.39). MTV and TLG are good prognostic factors in HNC, as high values predict a worse OS and DFS. Given the important information they provide, these parameters may be considered in clinical practice, as they are easily obtainable with current technology.Keywords
This publication has 40 references indexed in Scilit:
- Diagnosis, Staging, Radiation Treatment Response Assessment, and Outcome Prognostication of Head and Neck Cancers Using PET ImagingPET Clinics, 2020
- eIF4E and 4EBP1 are prognostic markers of head and neck squamous cell carcinoma recurrence after definitive surgery and adjuvant radiotherapyPLOS ONE, 2019
- Review of emerging biomarkers in head and neck squamous cell carcinoma in the era of immunotherapy and targeted therapyHead & Neck, 2019
- Biomarkers in Head and Neck Cancer an UpdateIndian Journal of Otolaryngology and Head & Neck Surgery, 2019
- What is the prognostic impact of FDG PET in locally advanced head and neck squamous cell carcinoma treated with concomitant chemo-radiotherapy? A systematic review and meta-analysisEuropean Journal of Nuclear Medicine and Molecular Imaging, 2018
- Staging Head and Neck Cancers2016
- PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck CancerNew England Journal of Medicine, 2016
- Prognostic Value of SUVmean in Oropharyngeal and Hypopharyngeal CancersClinical Nuclear Medicine, 2015
- Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis in Head and Neck Cancer: A Systematic Review and Meta-AnalysisJournal of Nuclear Medicine, 2014
- Head and Neck Tumours2010